Enseval Putera Megatrading Tbk PTEPMT:JKT

3,500
0.00 / 0.00%
0
5.41%
0.5047
Close in IDRToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 22 2014 04:31 BST.

About the company

14.94tn439.63bn19884.29k
Revenue in IDR (TTM)Net income in IDRIncorporatedEmployees
IndustryBiotechnology & DrugsLocation
Enseval Putera Megatrading Tbk PT
Jl. Pulo Lentut No. 10
Kawasan Industri Pulogadung
Pulo Gadung Industrial Area
JAKARTA TIMUR13920
Indonesia
IDN
Phone+62 214600200Fax+62 214609049Websitehttp://www.enseval.com
PT Enseval Putera Megatrading Tbk is an Indonesia-based company primarily engaged in distributing and trading pharmaceutical and consumer products. Its business is classified into four divisions: pharmaceutical products, comprising various ethical drugs; consumer products, comprising over-the-counter (OTC) drugs, nutritional supplements and other consumer goods; medical devices, and chemical materials, including the raw materials used in manufacturing veterinary medicines, pharmaceutical drugs, cosmetics and food. The Company operates a warehouse in Jakarta, Indonesia to distribute its products to the west regions of Indonesia. It also operates a warehouse in Surabaya, Indonesia as a distribution centre for the east regions of Indonesia. Both warehouses are equipped with refrigerated storages. The Company has numbers of branch offices throughout Indonesia to support its distribution activities.

Mergers & acquisitions

There are no recent mergers or acquisitions for Enseval Putera Megatrading Tbk PT.
Data delayed at least 15 minutes, as of Jul 22 2014 04:31 BST.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
Jilin Jian Yisheng Pharmaceutical Co Ltd
1.25tn164.71bn9.18tn1.83k55.732.96--7.350.26840.26842.045.060.36410.39513.70367,4074.819.105.379.1074.0372.7613.2015.913.34--0.087610.287.2315.61-9.632716.1243.29--
Huaren Pharmaceutical Co Ltd
1.68tn231.18bn9.19tn2.90k38.723.33--5.480.19030.19031.382.210.43213.222.58311,8475.929.078.669.0752.3654.8613.7018.041.137.190.287619.7854.3033.1025.8121.2211.72--
Shanghai Dingli Technology Development
2.33tn60.32bn9.66tn1.09k185.566.69--4.140.05730.05732.221.590.45820.85256.411,157,5451.365.563.215.5613.5014.032.965.750.48831.890.4823--20.9315.57-41.5772-4.4175-7.4573--
Fuan Pharmaceutical Group Co Ltd
689.92bn72.47bn9.74tn1.17k111.102.04--14.120.18180.18181.569.890.20131.916.12318,3322.139.232.269.2332.6040.2710.5822.938.57--0.000126.32-14.817912.51-56.6489-3.436637.91--
Staidson (Beijing) Biopharmaceuticals
1.71tn180.24bn9.76tn72754.163.90--5.700.40490.40493.845.620.60351.486.141,269,7156.3613.467.1813.4695.0693.2010.5324.945.62--0.0023.7160.5177.34-31.61946.176.50--
Tianjin Lisheng Pharmaceutical Co.,Ltd.
1.88tn475.78bn9.88tn2.05k20.761.78--5.241.411.415.5716.390.32261.7812.12494,7488.1512.488.5812.4862.9660.5525.2529.8210.30--0.043244.95-6.505412.000.32117.6937.01--
Shandong Luoxin Pharmacy Stock Co Ltd
4.73tn778.40bn9.42tn012.11----1.990.86070.86075.23------------29.44--29.4464.0861.7116.4422.55------27.2413.5230.52-2.566418.5311.9071.88
JCR Pharmaceuticals Co Ltd
1.78tn146.95bn9.17tn47261.573.2333.595.1540.5240.52490.84773.250.48511.163.5833,275,2404.003.984.853.9862.8064.078.256.842.17--0.14143.0511.395.3977.3919.1435.726.96
3-D Matrix Ltd
12.15bn-172.93bn9.55tn28--25.22--785.82-77.697-77.6975.46157.640.031.15-----42.7192-30.0234-57.8847-30.0234-461.677311.54-1,423.441-154.4422.93--0.2118--234.7461.12-55.9159------
TORII PHARMACEUTICAL CO., LTD.
6.59tn380.02bn9.74tn1.01k25.181.0719.341.48118.45118.452,053.322,792.130.633.382.6257,590,6803.633.254.273.2554.8057.785.775.024.83--0.00545.6811.129.2481.29-0.7239-4.85252.13
Green Cross Holdings
10.94tn485.59bn9.29tn11817.501.107.690.8491962.63962.6321,694.9615,136.440.62192.584.238,691,843,0005.493.8610.273.8631.7835.968.827.120.9362--0.191838.759.54-5.3185625.2415.369.276.58
Chabiotech Co Ltd
5.40tn183.67bn9.45tn28248.562.8620.141.75344.93296.269,948.235,852.750.789531.747.16--2.824.374.274.3721.3015.073.583.072.07--0.0574--10.3849.294.1441.6923.49--
Naturalendo Tech Co Ltd
----9.91tn--------------------------------------------------------------
PT Enseval Putera Megatrading Tbk.
14.94tn439.63bn9.21tn4.29k20.953.2225.530.6164162.31162.315,516.181,057.333.027.328.873,637,130,0008.8917.4316.3317.4311.3311.552.943.241.0125.900.050428.2026.0416.0014.7311.7019.81-39.5064
Data as of Jul 23 2014. Currency figures normalised to Enseval Putera Megatrading Tbk PT's reporting currency: Indonesian Rupiah IDR.
Data delayed at least 20 minutes, as of Jul 23 2014 06:09 BST.

Institutional shareholders

HolderShares% Held
RHB Asset Management Sdn Bhd.
as of 30 Sep 2013
148.50k0.01%
Forward Management LLC
as of 31 May 2014
77.50k0.00%
0.01%
Per cent of shares
held by top holders
Data from 28 Feb 2014 - 31 Mar 2014Source: FactSet Research Systems Inc.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.